Blockchain
4th Annual Digi-Tech Pharma & AI Conference, 2020 (London, United Kingdom – May 13-14, 2020)
Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) — The “Digi-Tech Pharma & AI 2020” conference has been added to ResearchAndMarkets.com’s offering.
The 4th Annual Digi-Tech Pharma & AI conference brings with it even more interactive sessions, expert speakers, senior professionals and decision-makers from leading pharma, biotech and healthcare industry.
Meet the decision-makers, benchmark and learn from real-life use cases to drive organizational change and to understand the new cutting-edge technologies and practical solutions.
In this 4th edition, as we explore the novel technologies and developments reforming the pharmaceutical industry, we also dive deep into the implementation and advances in machine learning, deep learning, artificial intelligence, informatics and data science which has redefined the development of new drugs, tackle diseases, improving healthcare and much more.
The enhancements in data management and data integration are providing improvements to both the speed and quality of drug discovery and many clinical trial processes. To be in the forefront, a necessity for partnership and collaboration with healthcare provider is a must for the pharmaceutical companies, and these partnerships will also lead to massive advances in R&D using artificial intelligence in genomics and precision medicine to develop a deep understanding of the root causes of diseases.
The combination of AI, big data and IoT technologies are creating new innovations, also other eminent technologies like cloud computing, augmented reality, virtual reality and blockchain are being used extensively in the Pharmaceutical industry’s digital transformation.
It gives us a great pleasure to welcoming you to this international pharmaceutical technology conference 4th Annual Digi-Tech Pharma & AI 2020.
Key Highlights
Reimagining Pharma by Integrating Science and Technology
- Digital Technology trends in Pharma and Bio-Tech industry
- Adopting AI and Machine Learning to unlock the full potential of Pharma
- How pharma can integrate into the digital health environment
- Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
- Patient Centred Drug Discovery
Digital Discovery and Clinical Trials
- Applying AI to the design of lead compounds for new drugs
- Algorithms and Models for drug discovery
- AI and ML for Target Identification & Validation in Drug Discovery
- Advancing Drug Discovery through quantum computing
- Genomics & Drug Discovery
- Virtual and Hybrid Clinical Trials
- R&D Use Cases
Decoding the Value of Data Science, Big Data & Informatics
- Implementation and relevance of FAIR data principles in Pharma R&D
- Harnessing Data Science for Drug Combination Discovery
- AI and Big Data: A powerful combination for future growth
- The use of AI to make sense of clinical data
- Use of big data for precision medicine
- Multi-omics & clinical data to unlock the power of complex datasets
- Integration and Visualization of translational Medicine Data
- Data & Healthcare Analytics
Real-World Data & Real-World Evidence
- The Growing Importance of Real-World Data
- RWD for clinical research and drug development
- RWE and RWD to support regulatory decision making
- RealWorld Data Science to advance Patient Care
- Managing real-world data governance
Digital Health & Future Innovations
- Healthcare & Medical Technology
- Adoption of IoT in Pharma
- Potential of Cloud Computing in Pharma
- Impact of Digital Health in Pharma
- Digital Health strategy and Patient-centric Clinical Trials
- The convergence of Digital Therapeutics and Pharma in Digital Health
- How pharma-health collaboration works on innovating drug discovery & patient experience
- Blockchain and AI-based Platform
Agenda
Day 1
08:15 – Registration & Refreshments
08:50 – Chairperson’s opening remarks
Digital Transformation & Pharma
09:00 – Accelerating Digital Transformation in Pharma
- Company leadership and transformation
- Need for communication specialists and up-to-date technologies
- Hiring digital experts and collaborations
- The need to be really quick in transforming at every level
09:30 – Executives Discussion and Debate: Adopting AI and Machine Learning to unlock the full potential of Big Pharma
- Innovation in Big-Pharma
- AI-enabled business models in R&D
- Achieving full potential of AI to boost Drug Discovery and Development
- AI has the capacity to radically reduce the uncertainty in both early and late-stage drug discovery and development
10:00 – Collaborative Innovation: Finding the right partners to leverage new technologies in Pharma
- How early-stage partnering and collaboration will inhibit pharma innovation
- How Biotech revolution has changed the face of drug development?
- Working with incubators, accelerators and innovation forums can also help
- Having a good governance structure in place
10:30 – Morning Coffee/Tea & Networking
AI-ML, Digital Discovery and Clinical Trials
10:50 – Advancing Drug Discovery via Artificial Intelligence
11:20 – Cutting-edge Computational Modelling and Deep Learning in Drug Discovery
11:50 – Maximizing Drug Discovery Success with Machine Learning
- Using machine learning to integrate distinct, bigger datasets created from high throughput screening data can provide a path to predict bioactivities for targets and molecular properties with increased levels of accuracy
- Broader applicability of machine learning and the potential to change the drug development paradigm
- ML tools that can improve discovery and decision making
12:20 – Networking & Luncheon
13:00 – Combining robotics and AI for data-driven drug discovery
Genomics and Precision Medicine
13:30 – Enabling precision medicine with integrated genomic and clinical data
- Transforming the entire pharmaceutical value chain
- How do we implement Precision Medicine in the Real World?
- How does it affect the ecosystem of healthcare?
- Future of genomics and precision medicine
14:00 – Powering Precision Medicine with Artificial Intelligence – AI to further advance drug combination design and development of precision medicine
Data Science, Big Data & Informatics
14:30 – Implementation and relevance of FAIR data principles in Pharmaceutical R&D
- Improving the efficiency and effectiveness by implementing the FAIR guiding principles for scientific data
- Tools enabling FAIR data
- Fair as a machine learning enabler
- Benefits of FAIR in pharma
15:00 – Afternoon Networking Tea Break
15:20 – Big data & AI in Pharma: How Data, AI and externalisation strategy impacts Drug Discovery
- Importance of big data in decision making
- Predominantly with pipelines paying attention on treatments for rare diseases
- Need for data integration and collaborations for free flow of information
- Getting big data ready for AI
15:50 – Integration and Visualization of translational Medicine Data
16:20 – Case Study on Data and Patient Engagement: PsoHappy: Tactics to Massively Scale Patient Engagement
- Why we need to rethink how we measure the quality of life when we engage patients
- Scaling up Data – How LEO Innovation Lab engaged over 200,000 psoriasis patients across 184 countries
- Impact update: supporting IFPA and national patient associations to ensure insights can be utilized in supporting advocacy efforts
- Pitfalls of current health-related quality measures we employ in clinical trials
16:50 – Round Table Discussion:
- All the participants will have a great opportunity to discuss and explore a selection of the most interesting topics discussed during the conference in small groups with their industry colleagues in an informal setting.
- Each table will nominate a head who will summarise the discussion and questions posed. The group members are given equal rights to share and learn from each other’s experiences to discover an actionable solution on the discussed topic.
17:20 – Chairperson’s closing remarks
17:30 – Networking Drinks Session
Day 2
08:15 – Registration & Morning Coffee
08:50 – Chairperson’s opening remarks
Real-World Data & Real World Evidence
09:00 – Real World Evidence model for assessing new drugs – Enhancing Real World Data Environment
- How RWE model can be used in R&D to accelerate new product developments?
- Integrated evidence development model
- Building an effective RWE based capabilities system
- Advantages of implementing AI and ML
09:30 – Integration and Analysis of Real-World Data (RWD) for clinical research and drug development
- Leveraging Real-World Data to Overcome the Inefficiencies of Drug Development
- Understanding the clinical processes
- RWD to create novel, faster and less invasive approaches to advance disease understanding and biomarker discovery
- RWD for EHRs in last phase research studies
- Real-World Data in the clinical study through a decentralized approach
10:00 – Real-World Data Science to Advance Patient Care
10:30 – Morning Coffee/Tea & Networking
10:50 – RWE and RWD to support evidence generation for regulatory approval and market access
Data Visualization, IoT and Cloud
11:20 – How Pharma can leverage Cloud Computing and AI to increase access to the broadest range of data in Drug Discovery and Design?
- BI & Analytics in cloud
- Decentralized IT infrastructure
- Scalability and flexibility
- How can efficiency be improved?
11:50 – Data Visualization Innovations in Life Sciences and Drug Discovery – AI, VR and MR to Support Drug Discovery
12:20 – Networking & Luncheon
13:00 – Adoption of IoT in Pharma
- Potential benefits of the IoT on clinical research
- Data processing and management
- Patient safety and automated monitoring systems
- Challenges in regulatory approval and compliance
Digital Health in Pharma & Future Innovation
13:30 – Potential impact of Digital Health in Pharma
- Strategies for efficient collaboration
- Digital health is proving to be a valuable asset for the pharma industry
- The intersection of health-care and pharma are together transforming the customer journey
- Identifying other areas that need to be looked at
- Innovation is key to the future
14:00 – Digital Innovation and Predictive Technology in Respiratory Medicine
14:30 – Blockchain technology to improve efficiency and safety
15:00 – Afternoon Networking Tea Break
15:50 – The convergence of Digital Therapeutics and Pharma in Digital Health
- Pharma-digital therapeutic alliances
- Making treatment more accessible
- How to fit it into the pharmaceutical workflow
16:20 – Panel Discussion: Emerging technologies and how pharma-health collaboration works on innovating drug discovery & patient experience
- The changing patient behaviour in the digital era
- Why is it essential to be prompt in identifying and addressing the patient’s needs?
- How will digitization help bring patients on board?
- Progress made by companies so far
- Strategies to be adopted to increase patient -company data flow
- Emergence of wearable tech-potential benefits
16:50 – Chairperson’s Closing Remarks and End of the Conference
For more information about this conference visit https://www.researchandmarkets.com/r/p0dgkq
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Blockchain
Blocks & Headlines: Today in Blockchain – May 30, 2025 (Fraser Edwards, Kyiv NFT, Spirit Blockchain Capital, Indian eHealth, Hedera)
Blockchain technology and cryptocurrencies continue to redefine industries—from competitive gaming and cultural heritage preservation to corporate finance, healthcare, and alternative tokens. Today’s briefing highlights five pivotal developments shaping the ecosystem: Fraser Edwards’s vision for trust in eSports; Ukraine’s wartime cultural preservation via NFTs; Spirit Blockchain Capital’s Q1 2025 operational report; India’s push for blockchain-enabled electronic health records (EHRs); and the rise of viral altcoins such as UniLabs, Sui, and Hedera Hashgraph. Together, these stories illustrate the themes of trust and identity, preservation and provenance, institutional maturation, public-sector innovation, and token diversification. In this op-ed–style round-up, we distill the essence of each story, cite sources, and offer analysis on how they advance Web3, DeFi, and NFT frontiers.
1. Rebuilding Trust in eSports: Can Blockchain Fix Competitive Integrity?
Source: CCN
Summary:
In a recent CCN interview, veteran trader and eSports investor Fraser Edwards argues that blockchain’s immutable ledgers can restore credibility in the rapidly commercializing world of competitive gaming. According to Edwards, match-fixing scandals and opaque prize-pool distributions have eroded fan confidence. By tokenizing tournament entries and payouts on public blockchains—complete with smart-contract–enforced escrow—organizers can guarantee that prize monies are distributed exactly as advertised, and that no post-match manipulation occurs. Tournament operators in Asia and North America are already piloting Ethereum-based payout dApps, aiming to increase transparency for players and sponsors alike.
Key details & analysis:
-
Smart-contract escrow: Funds are held in a time-locked contract that releases prize money only upon verifiable match results. This prevents disputes over referee decisions or delayed payments.
-
On-chain reputation: Player and team reputations can be tokenized via non-fungible reputation badges that accrue based on fair play and community votes—discouraging cheating.
-
Scalability concerns: High-traffic tournaments may require Layer 2 rollups or alternative chains (e.g., Polygon, Immutable X) to reduce gas costs and latency.
Opinion: Blockchain’s dual promise of provable fairness and programmable finance makes it uniquely suited to eSports. Yet adoption hinges on UX: seamless wallet integrations, minimal transaction fees, and clear regulatory guidance on esports tokens.
2. When Art Meets Blockchain: Ukraine’s Wartime Cultural Preservation
Source: The Kyiv Independent
Summary:
As monuments crumble under artillery fire, Ukrainian curators and technologists are partnering to mint NFTs representing lost or endangered artifacts. The Kyiv Independent reports that the National Art Museum of Ukraine has launched “Project Phoenix,” tokenizing high-resolution 3D scans of sculptures, manuscripts, and paintings. Proceeds from initial sales fund restoration and digital archiving efforts. Each NFT embeds provenance metadata—including GPS coordinates, curator notes, and condition reports—ensuring that future generations can verify authenticity and context, even if the physical artifact is destroyed.
Key details & analysis:
-
Metadata richness: Beyond simple ownership, NFTs store structured metadata—using ERC-721 metadata extensions—that capture curatorial insights and conservation logs.
-
Decentralized archives: IPFS and Arweave are employed to host ultra-high-resolution imagery, with on-chain hashes guaranteeing data integrity.
-
Community engagement: Fractional-NFT drops allow diaspora communities to collectively own tokens, strengthening cultural ties and crowdfunding preservation.
Opinion: Blockchain’s ability to immutable record heritage provides a lifeline for war-torn nations. However, ensuring that local institutions retain governance over metadata edits and future migrations is critical to avoiding “cultural colonialism” by global NFT marketplaces.
3. Spirit Blockchain Capital’s Q1 2025 Highlights: Growth, Investments, and Outlook
Source: GlobeNewswire
Summary:
Spirit Blockchain Capital’s Q1 2025 report benchmarks the firm’s operational milestones and financial performance. Assets under management (AUM) climbed 45% to $1.02 billion, driven by strategic allocations to top-tier Layer 1 and Layer 2 protocols, DeFi liquidity pools, and a newly launched token-index fund. Operating income rose 37%, fueled by management fees and performance incentives. The firm also closed its second blockchain-focused venture fund at $150 million, earmarked for early-stage Web3 projects in gaming, infrastructure, and decentralized identity.
Key details & analysis:
-
Diversification strategy: 60% of AUM in blue-chip cryptocurrencies (Bitcoin, Ethereum); 25% in DeFi (Aave, Uniswap, Lido); 15% in tokenized commodities and NFTs.
-
Fund performance: The flagship fund delivered a 9.8% return in Q1, outperforming the 6.2% benchmark set by the Bloomberg Galaxy Crypto Index.
-
Venture investments: Early stakes in zero-knowledge proof startups and decentralized storage platforms signal confidence in scalability and privacy innovations.
Opinion: Spirit’s robust growth and disciplined diversification mirror institutional maturation in the blockchain asset management space. As regulatory clarity improves, expect further inflows from endowments, pensions, and family offices.
4. Blockchain EHRs in India: The Next Digital Health Revolution
Source: ORF
Summary:
The Observer Research Foundation (ORF) details India’s pioneering pilot of blockchain-backed electronic health records (EHRs) in the state of Andhra Pradesh. By leveraging a permissioned Hyperledger Fabric network, the initiative ensures that patient records—from vaccination histories to diagnostic imaging—are securely shared across hospitals, clinics, and pharmacies. Patients control access via digital identities anchored to India’s Aadhaar system, granting temporal permissions for data viewing and preventing unauthorized sharing.
Key details & analysis:
-
Interoperability: HL7 FHIR standards are mapped to on-chain transactions, enabling seamless data exchange with existing hospital information systems (HIS).
-
Privacy safeguards: Off-chain storage of PHI (Protected Health Information) is encrypted with patient-held keys; only hashed pointers reside on-chain to ensure immutability without exposing sensitive data.
-
Regulatory alignment: The pilot aligns with India’s draft Digital Health Act, which emphasizes data sovereignty and patient consent frameworks.
Opinion: Blockchain EHRs can democratize healthcare access in a populous nation—but success depends on user-friendly portals, robust identity verification, and contingency plans for network outages in rural areas.
5. The Hottest Viral Altcoins of 2025: UniLabs, Sui, and Hedera Lead the Pack
Source: TronWeekly
Summary:
According to TronWeekly, the altcoin landscape in 2025 is dominated by three viral tokens: UniLabs (UNI-L), Sui (SUI), and Hedera Hashgraph (HBAR). UniLabs, a governance token for a decentralized laboratory network, saw a 1,200% year-to-date surge on news of its AI-driven drug-discovery partnership. Sui’s Move-based smart-contract platform gained traction for sub-second finality and low gas fees, with total value locked (TVL) surpassing $2 billion. Hedera’s HBAR continues its enterprise pivot, securing multi-year agreements with global brands for identity verification and supply-chain tracking.
Key details & analysis:
-
UniLabs use case: Token holders vote on research grants and share in royalty revenues from patented compounds developed on-chain.
-
Sui performance: With a novel object model and horizontal sharding, Sui supports over 3,000 TPS (transactions per second) without compromising on decentralization.
-
Hedera enterprise: The Governing Council—comprising Boeing, Google, and LG—bolsters confidence in HBAR’s governance model and paves the way for compliant enterprise deployments.
Opinion: These tokens exemplify the diversification of blockchain applications. Investors should assess not only market hype but also protocol fundamentals—developer activity, economic incentives, and real-world adoption.
Cross-Story Trends & Key Takeaways
-
Trust & Transparency at the Core
From esports prize-pool ledgers to wartime NFT archives and permissioned health records, blockchain’s immutability fosters verifiable trust—a prerequisite for mainstream adoption across sectors. -
Institutional & Public-Sector Innovation
Spirit Blockchain Capital’s fund growth and India’s EHR pilot signal that both private and government entities view blockchain as a strategic infrastructure, not just speculative assets. -
Vertical Specialization Fuels Token Growth
Viral altcoins like UniLabs, Sui, and Hedera thrive by addressing niche use-cases—governance in biotech, scalable DeFi rails, and enterprise identity—underscoring the importance of purpose-built protocols. -
Metadata & Provenance Drive NFTs Beyond Art
Ukraine’s cultural NFTs demonstrate how rich on-chain metadata can preserve heritage, while esports applications show that reputation tokens can enforce fair-play credentials. -
Ecosystem Maturation Requires UX & Governance
Across all stories, user experience—wallet onboarding, identity verification, metadata curation—and robust governance frameworks (tokenomics, regulatory alignment) emerge as decisive factors in blockchain’s next wave.
Conclusion
Today’s blockchain headlines reveal a maturing ecosystem where trust, transparency, and targeted innovation unlock new frontiers—from safeguarding digital heritage amid conflict to revolutionizing healthcare and sports. As institutional players allocate billions, and public-sector pilots chart regulatory pathways, the fate of tomorrow’s Web3 landscape hinges on seamless UX, rigorous governance, and demonstrable real-world utility. Stay tuned for tomorrow’s Blocks & Headlines, where we’ll continue tracking the trends, tokens, and technologies that define the blockchain revolution.
The post Blocks & Headlines: Today in Blockchain – May 30, 2025 (Fraser Edwards, Kyiv NFT, Spirit Blockchain Capital, Indian eHealth, Hedera) appeared first on News, Events, Advertising Options.
Blockchain
Kyrgyz Republic to launch USDKG, a gold-backed stablecoin pegged to the U.S. Dollar, in Q3 2025
USDKG
-
Blockchain Press Releases2 days agoRain Expands Support to Solana, Tron, and Stellar, Enabling More Partners to Launch Stablecoin-powered Card Programs
-
Blockchain Press Releases4 days agoFlipster Reveals Middle East Expansion Plans and Appoints Regional Leadership to Bolster Crypto Trading
-
Blockchain Press Releases4 days agoCoinW Teams Up with Superteam Europe to Conclude Solana Hackathon and Accelerate Web3 Innovation in Europe
-
Blockchain4 days agoBlocks & Headlines: Today in Blockchain – May 27, 2025 Featuring Blockchain.com, Bilal Bin Saqib, XRP Ledger, Unstoppable Domains, ReNEW, MEXC Ventures
-
Blockchain5 days ago
Blocks & Headlines: Today in Blockchain – May 26, 2025 (Lightchain AI, Cetus Hack, Bilal Bin Saqib, The Blockchain Group)
-
Blockchain Press Releases2 days ago
Bybit Secures MiCAR License in Austria, Opens European Headquarters in Vienna with Strategic Expansion Plan
-
Blockchain Press Releases5 days agoAB Charity Foundation X AB Blockchain Join Forces to Advance the Global “Tech for Good” Mission
-
Blockchain5 days agoFinfra Astra Fintech Launches Canada’s First Solana Accelerator in Partnership with MixMarvel — Named ‘AMS’
